ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Clinical trial NCT01360554 · COMPLETED
Trial details
- NCT number
- NCT01360554
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-16
- Primary completion
- 2013-09-30
- Enrollment
- 878
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.